MedTrace Logo

Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients

NCT01364779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2013-05-15

No results posted yet for this study

Summary

The primary objective of the study is to determine the prevalence of aspirin resistance in chronic kidney disease patients. The secondary objectives are to determine possible risk factors contributing to aspirin resistance in this population.

Conditions

Sponsors & Collaborators

  • Staten Island University Hospital

    collaborator OTHER

  • Northwell Health

    lead OTHER

Principal Investigators

  • Suzanne El_Sayegh, MD · Staten Island University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01364779 on ClinicalTrials.gov